Medler J, Kucka K, Melo Galegos V, Zhang T, von Rotenhan S, Ulrich J, Bremer E, Hudecek M, Beilhack A, Wajant H. (2021).
CD40- and 41BB-specific antibody fusion proteins with PDL1 blockade-restricted agonism.
Theranostics. 2022; 12(4):1486-1499.
Cendrowicz E, Jacob L, Greenwald S, Tamir A, Pecker I, Tabakman R, Ghantous L, Tamir L, Kahn R, Avichzer J, Aronin A, Amsili S, Zorde-Khvalevsky E, Gozlan Y, Vlaming M, Huls G, van Meerten T, Elhalel Dranitzki M, Foley-Comer A, Pereg Y, Peled A, Chajut A, Bremer E.
DSP107 combines inhibition of CD47/SIRPα axis with activation of 4-1BB to trigger anticancer immunity.
Journal of Experimental and Clinical Research (in press).